Fulgent Genetics (FLGT) Gross Profit (2015 - 2026)

Fulgent Genetics has disclosed Gross Profit across 12 years of filings, most recently posting $21.5 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $21.5 million, down 24.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $124.0 million (up 9.31% YoY), and the FY2025 annual result was $130.9 million, up 22.07% from the prior year.
• Gross Profit came in at $21.5 million for Q1 2026 at Fulgent Genetics, down from $32.6 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $242.5 million in Q1 2022 to a low of $13.0 million in Q4 2022.
• The 5-year median for Gross Profit is $28.3 million (2025), against an average of $43.0 million.
• Across the five-year window, Gross Profit tumbled 93.15% in 2022 and surged 94.26% in 2023, its largest moves.
• Fulgent Genetics' Gross Profit stood at $13.0 million in 2022, then soared by 94.26% to $25.2 million in 2023, then grew by 26.24% to $31.8 million in 2024, then climbed by 2.3% to $32.6 million in 2025, then plunged by 34.04% to $21.5 million in 2026.
• The last three Gross Profit figures came in at $21.5 million (Q1 2026), $32.6 million (Q4 2025), and $35.5 million (Q3 2025), per Business Quant data.